Chronic kidney disease (CKD) affects more than 700 million people worldwide and is caused by genetic and environmental ...

A new drug lowered blood pressure and improved kidney health markers in high-risk patients. Phase 3 trials will test its long-term effects. Preliminary research suggests that adding the new medication ...

A study published today in Nature Structural & Molecular Biology is the first time researchers have shown evidence that a ...

A diagnosis of kidney cancer, also known as renal cancer, requires strong partnership with your oncologist. This overview is ...

Implantable biosensors and wearable technologies have the potential to enable continuous, real-time monitoring of kidney and ...

Researchers say the catalog has already led to the identification of genetic mechanisms involved in kidney cancer and will ...

Dr. Lerman's Renovascular Research Lab at Mayo Clinic studies ways to improve atherosclerotic renal artery stenosis, ...

Chronic kidney disease (CKD) affects more than 700 million people worldwide and is caused by genetic and environmental factors, as well as existing medical conditions. Known genetic risk factors for ...

A study published in Nature Structural & Molecular Biology is the first time researchers have shown evidence that a single ...

The Lerman Renovascular Research Lab at Mayo Clinic studies causes and treatments related to nephropathy from atherosclerotic ...